Abstract:Abstract Backgroud: High tumor-infiltrating lymphocytes(TILs)are known to be associated with response to primary systemic therapy (PST) in breast cancer patients especially in Her2+ and triple negative patients. However, the composition of TILs in the high infiltration group is largely unknown. Uncovering the immunodynamic composition of TILs may be useful for better understanding the mechanism how the TILs exert effect. And the immune reservoir data for extensive analysis of altered TIL subsets after chemotherapy is still lacking. Methods: The tumor specimens of 56 breast cancer patients who did not receive PST and 16 breast cancer patients who underwent surgical resection after anthracycline- or anthracycline/taxane-based PST were analysed. We used the multi -parametric flow cytometric platform (optimized for 20 colors for each panel of T cells, B cells, NK, and other Lineage markers detection) to accomplish the purpose. The result is more objective and estimated parameter is more abundant compared to the histological methods (hematoxylin-eosin staining and immunohistochemical staining). Breast cancer patients can be divided into low, medium and high infiltration group according to the CD45+ number in the tissue and weight of the tumor specimens. TIL subset composition is compared among different groups (Low vs Medium vs High, Chemotherapy vs non Chemotherapy). Result: In patients with ER- and high histological grade patients, there are more TILs infiltration compared to the ER+ and low histological grade patients (P = 0.038 and P = 0.039 respectively). And we found that the percentage of CD4+T cells in total CD3+T cells, Treg in CD4+T cells and Plasmablasts in total B cells is much higher in the high infiltration group compared to the low infiltration group (56.03% vs 44.21%, P<0.01; 18.64% vs 9.37%, P<0.001; 16.75% vs 1.88%, P<0.001 respectively). By contrast, percentage of CD8+T in total CD3+T cells and NK cells in the total lymphocytes is much lower (35.26% vs 46.71%, P<0.001; 2.74% vs 5.88%, P<0.01 respectively). After PST both the percentage of CD8+T in total CD3+T cells and effector memory CD8+T cells increase heavily (53.82% vs 41.14%, P<0.001; 79.49% vs70.88%, P<0.05 respectively) and percentage of CD4+T cells in total CD3+T and naïve CD8+T cells decrease (31.81% vs 50.35%, P<0.001; 2.81% vs 4.21%, P<0.05 respectively). Functional markers such as HLADR,CD28 and PD1 in the T cells decrease dramatically and CD127 increases noticeably. Conclusion: The inner composition of TIL subsets in the high infiltration is largely different from low infiltration group and this might help explain the reason why high TILs could predict pathological complete response. Chemotherapy can lead to the heavy change of TIL subsets and this may be the part of immunological mechanism that why chemotherapy has deep influences on the tumor. Citation Format: Liang Guo, Yayun Chi, Jingyan Xue, Shyamal Goswami, Bingqing Zhou, Chunmei Cao, Zhimin Shao, Xiaoming Zhang, Jiong Wu. Composition and distribution of tumor-infiltrating lymphocytes in breast cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4075.

Cytokine Plasma Levels in Breast Cancer Patients, Before and After Surgery

Abstract P4-11-21: Plasma cytokine levels in breast cancer-related lymphedema patients

Abstract P6-14-13: Association of baseline tumor-infiltrating lymphocytes and cell-cycle regulation markers on prognosis and mortality in patients with advanced breast cancer according to tumor characteristics and treatment type

Dysregulation of immune checkpoint proteins in patients with newly diagnosed early breast cancer undergoing neoadjuvant chemotherapy: A comparison between patients with triple negative breast cancer (TNBC) and non-TNBC.

Tumor-promoting roles of IL-4 and TGF-β3, their implications in the progression of breast tumors

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer

Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients

Changes of CD4+, CD8+ and B cells in peripheral blood of breast cancer patients detected before and after surgery and following chemotherapy and their clinical significance

EP032/#1390 Tumor-infiltrating Lymphocytes: a Prognostic Biomarker in Neoadjuvant-Treated HR Positive/her2 Negative Breast Cancer

IL-6, IL-8 and TNF-α Levels Correlate with Disease Stage in Breast Cancer Patients

Abstract 4075: Composition and Distribution of Tumor-Infiltrating Lymphocytes in Breast Cancer

Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy

Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations

57: EVALUATION OF THE CIRCULATING LEVELS OF IL-12 AND IL-33 IN PATIENTS WITH BREAST CANCER: INFLUENCES OF THE TUMOR STAGES AND CYTOKINE GENE POLYMORPHISMS

The cytokine profile correlates with less tumor-infiltrating lymphocytes in luminal A breast cancer

Systemic immune mediators reflect tumour-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast cancer

Abstract PO4-03-09: Profile of circulating natural killer cells in stage III triple negative breast cancer before and after neoadjuvant chemotherapy

Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapy

Composition And Distribution Of Tumor Infiltrating Lymphocytes In Breast Cancer

The immunomodulatory impacts of endocrine therapy on host immunity in early-stage hormone receptor positive, HER2 negative breast cancer.

Increased Stromal Infiltrating Lymphocytes Are Associated with Circulating Tumor Cells and Metastatic Relapse in Breast Cancer Patients after Neoadjuvant Chemotherapy.